Meghmani Organics Ltd

Meghmani Organi. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Meghmani Organics Ltd

₹ 79.0 -0.50%
22 Jul 12:24 p.m.
meghmani.com BSE: 543331 NSE: MOL
About

Founded in 1986 as M/s Gujarat Industries, the company was incorporated in 1995 as Meghmani Organics Limited. The company manufactures Pigments and Agrochemicals through its 6 manufacturing facilities located in Gujarat. The company is amongst the top 3 Phthalocyanine based pigment players in the world and amongst the top 10 producers of pesticides in India.[1]Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber.

It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage.

Key Points

Business Segments
A) Agro Chemicals (68% in FY24 vs 74% in FY23): [1] The co. manufactures and markets technicals, intermediates, and formulation of crop protection chemicals. Products include Insecticides, Herbicides, and Fungicides. Key intermediates are cypermethrin acid chloride, meta phenoxy benzaldehyde, and meta phenoxy benzyl alcohol. [2] [3]

Website BSE NSE
  • Market Cap ₹ 2,009 Cr.
  • Current Price ₹ 79.0
  • High / Low ₹ 104 / 71.4
  • Stock P/E
  • Book Value ₹ 60.1
  • Dividend Yield 1.80 %
  • ROCE -3.13 %
  • ROE -6.71 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Company has a low return on equity of 9.24% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.36.7 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
463 498 548 640 812 783 646 549 574 426 379 352 410
428 410 470 562 678 652 567 497 496 448 371 360 408
Operating Profit 35 88 78 78 134 132 78 53 78 -22 8 -8 2
OPM % 8% 18% 14% 12% 16% 17% 12% 10% 14% -5% 2% -2% 0%
18 28 21 26 27 38 26 24 27 7 12 10 9
Interest -9 9 -4 -3 7 9 -3 43 16 4 13 27 2
Depreciation 14 15 15 15 17 18 18 18 23 24 23 23 23
Profit before tax 48 92 88 93 136 142 89 15 67 -43 -16 -48 -14
Tax % 25% 25% 26% 26% 25% 23% 25% 46% 19% -20% -3% -20% 25%
36 69 65 68 102 109 66 8 54 -34 -15 -38 -18
EPS in Rs 7,206.00 2.70 2.57 2.69 4.02 4.29 2.60 0.33 2.13 -1.36 -0.60 -1.50 -0.71
Raw PDF
Upcoming result date: 27 July 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
700 1,637 2,498 2,553 1,566
595 1,353 2,119 2,211 1,586
Operating Profit 105 283 379 342 -19
OPM % 15% 17% 15% 13% -1%
130 30 102 114 37
Interest 18 11 9 66 46
Depreciation 22 51 63 77 92
Profit before tax 194 252 409 313 -121
Tax % 23% 26% 26% 24% -12%
150 186 304 238 -106
EPS in Rs 29,914.00 37,296.00 11.97 9.35 -4.17
Dividend Payout % 17% 19% 12% 15% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: -1%
TTM: -39%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -148%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -4%
Return on Equity
10 Years: %
5 Years: %
3 Years: 9%
Last Year: -7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 25 25 25 25 25
Reserves 961 1,148 1,441 1,644 1,502
264 268 499 824 837
407 533 832 705 676
Total Liabilities 1,657 1,974 2,798 3,198 3,040
481 634 911 1,166 1,152
CWIP 101 112 188 356 521
Investments 191 304 211 183 114
885 924 1,487 1,494 1,253
Total Assets 1,657 1,974 2,798 3,198 3,040

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
22 333 65 204 250
13 -307 -133 -418 -178
-26 -14 58 234 -85
Net Cash Flow 8 12 -10 21 -14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 241 92 79 75 101
Inventory Days 271 152 161 158 185
Days Payable 209 137 144 108 176
Cash Conversion Cycle 302 106 96 124 109
Working Capital Days 239 89 99 113 134
ROCE % 19% 24% 16% -3%

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
51.51% 49.36% 49.41% 49.29% 49.37% 49.37% 49.48% 49.50% 49.32% 49.32% 49.32% 49.32%
1.34% 1.25% 1.25% 1.44% 1.64% 1.57% 1.53% 1.50% 1.34% 1.30% 1.52% 1.39%
0.00% 0.00% 0.00% 0.00% 0.08% 0.34% 0.45% 0.45% 0.61% 0.26% 0.20% 0.20%
0.00% 0.00% 0.04% 0.05% 0.05% 0.05% 0.05% 0.04% 0.04% 0.04% 0.04% 0.04%
47.14% 49.38% 49.29% 49.23% 48.87% 48.69% 48.50% 48.51% 48.69% 49.09% 48.93% 49.05%
No. of Shareholders 1,18,9781,26,6141,27,3061,29,4061,30,9921,28,5071,27,1981,31,3361,40,6721,40,8291,52,7031,46,010

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls